326 related articles for article (PubMed ID: 17456294)
1. Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion.
Elsammak M MY; Morsi TS; Khamis HI; Ragab MS; Zaki MA; Abdel-Hadi M; Hassan HA
Ann Clin Biochem; 2007 May; 44(Pt 3):264-72. PubMed ID: 17456294
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
[TBL] [Abstract][Full Text] [Related]
3. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
[TBL] [Abstract][Full Text] [Related]
4. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
Castaño Vidriales JL; Amores Antequera C
Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
[TBL] [Abstract][Full Text] [Related]
5. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
6. Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.
Valdés L; San-José E; Ferreiro L; Golpe A; González-Barcala FJ; Toubes ME; Rodríguez-Álvarez MX; Álvarez-Dobaño JM; Rodríguez-Núñez N; Rábade C; Gude F
Clin Respir J; 2015 Apr; 9(2):203-13. PubMed ID: 25849297
[TBL] [Abstract][Full Text] [Related]
7. Role of pleural viscosity in the differential diagnosis of exudative pleural effusion.
Yetkin O; Tek I; Yetkin F; Numanoglu N
Respirology; 2007 Mar; 12(2):267-71. PubMed ID: 17298461
[TBL] [Abstract][Full Text] [Related]
8. [Role of c-c chemokines in the determination of pleural effusion etiology].
Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
[TBL] [Abstract][Full Text] [Related]
10. Differentiating tuberculous from malignant pleural effusions: a scoring model.
Porcel JM; Vives M
Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
[TBL] [Abstract][Full Text] [Related]
11. Pleural adenosine deaminase in the separation of transudative and exudative pleural effusions.
Atalay F; Ernam D; Hasanoglu HC; Karalezli A; Kaplan O
Clin Biochem; 2005 Dec; 38(12):1066-70. PubMed ID: 16226239
[TBL] [Abstract][Full Text] [Related]
12. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
[TBL] [Abstract][Full Text] [Related]
13. Pleural fluid and serum soluble interleukin-2 receptors in pleural effusions.
Sarandakou A; Poulakis N; Rizos D; Phocas I
Anticancer Res; 1991; 11(3):1365-8. PubMed ID: 1888173
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of exudative pleural effusions based on multiple biological parameters.
Daniil ZD; Zintzaras E; Kiropoulos T; Papaioannou AI; Koutsokera A; Kastanis A; Gourgoulianis KI
Eur Respir J; 2007 Nov; 30(5):957-64. PubMed ID: 17690119
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis.
Garcia-Pachon E; Soler MJ; Padilla-Navas I; Romero V; Shum C
Respiration; 2005; 72(5):486-9. PubMed ID: 16210887
[TBL] [Abstract][Full Text] [Related]
16. Role of biochemical tests in the diagnosis of exudative pleural effusions.
Ernam D; Atalay F; Hasanoglu HC; Kaplan O
Clin Biochem; 2005 Jan; 38(1):19-23. PubMed ID: 15607312
[TBL] [Abstract][Full Text] [Related]
17. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions.
Liam CK; Lim KH; Wong CM
Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486
[TBL] [Abstract][Full Text] [Related]
18. Prolidase activity in serum and pleural fluids in patients with tuberculous pleural effusion [correction of effussion].
Ipcioglu OM; Ozcan O; Gultepe M; Deniz O; Akgul EO
Clin Biochem; 2008 Jun; 41(9):670-5. PubMed ID: 18387361
[TBL] [Abstract][Full Text] [Related]
19. Use of acute phase proteins in pleural effusion discrimination.
Calikoğlu M; Sezer C; Unlü A; Kanik A; Tamer L; Calikoğlu I
Tuberk Toraks; 2004; 52(2):122-9. PubMed ID: 15241695
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
Ni SS; Gao ZL
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
